Chester County News and Community Website
BERYWN, PA — In a significant move that promises to reshape the future of pain management, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced its intent to submit an Investigational New …
Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management Read More
BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biopharmaceutical company focused on developing novel treatments for neurodegenerative diseases, recently announced a significant milestone in its clinical trial journey. The …
Annovis Bio’s Buntanetap Trial for Alzheimer’s Disease Gets Green Light from DSMB: A Positive Step Forward Read More
MALVERN, PA — In a significant corporate update, Chester County-based biotechnology firm Baudax Bio, Inc. (NASDAQ: BXRX) this week announced plans to initiate the clinical development of its groundbreaking therapy, …
Baudax Bio Prepares for Pioneering Clinical Development of TI-168, Aiming to Improve Hemophilia A Treatment Read More BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced that the cooperative research and development agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) to evaluate Virpax’s …
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research Read More
MALVERN, PA — Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company, announced the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within …
Venatorx Pharmaceuticals Awarded a Third Antibiotic BARDA Contract Read More
RADNOR, PA — Aclipse Therapeutics, and its subsidiary, Aclipse Two, Inc, a biopharmaceutical company, recently announced that it has signed an exclusive license agreement with Seoul, South Korea-based Chong Kun …
Aclipse Therapeutics Expands Drug Development Pipeline with Signing of Exclusive, Worldwide License Agreement with Chong Kun Dang Pharmaceutical Corporation Read More
PHILADELPHIA, PA — Mispro is set to open a full-service vivarium facility in Philadelphia’s thriving UCity biocluster in January 2024.
Mispro to Open Contract Vivarium in Philadelphia’s UCity Biocluster Read More BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) announced that it has engaged Dr. Pardeep Gupta, a leading expert in liposomal drug delivery and nanotechnology, to support the development of Probudur, Virpax’s …
Virpax Pharmaceuticals Enlists Leading Expert for Development of Pain Management Injectable Read More
WEST CHESTER, PA — The Chester County History Center (CCHC) announced that it will host the world premiere of the documentary The Mushroom Man Who Changed the World: G. Raymond …
World Premiere Documentary Unveils the Life of the West Chester Native Who Changed the World Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) announced that it has engaged two leading physicians experienced in childhood epilepsy, Dr. Kenneth W. Sommerville and Dr. Lawrence Fried, to support …
Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol Read More